IL161468A0 - Method of producing human beta cell lines - Google Patents

Method of producing human beta cell lines

Info

Publication number
IL161468A0
IL161468A0 IL16146802A IL16146802A IL161468A0 IL 161468 A0 IL161468 A0 IL 161468A0 IL 16146802 A IL16146802 A IL 16146802A IL 16146802 A IL16146802 A IL 16146802A IL 161468 A0 IL161468 A0 IL 161468A0
Authority
IL
Israel
Prior art keywords
human beta
pancreatic
beta cell
cell lines
producing human
Prior art date
Application number
IL16146802A
Other languages
English (en)
Original Assignee
Univ Paris 7 Denis Diderot Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris 7 Denis Diderot Ct filed Critical Univ Paris 7 Denis Diderot Ct
Publication of IL161468A0 publication Critical patent/IL161468A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/39Pancreas; Islets of Langerhans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • C12N5/0678Stem cells; Progenitor cells; Precursor cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/04Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL16146802A 2001-10-19 2002-10-18 Method of producing human beta cell lines IL161468A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/981,750 US20030077256A1 (en) 2001-10-19 2001-10-19 Pancreas regeneration using embryonic pancreatic cells
PCT/IB2002/004599 WO2003033685A2 (fr) 2001-10-19 2002-10-18 Procede destine a produire des lignees cellulaires beta humaines

Publications (1)

Publication Number Publication Date
IL161468A0 true IL161468A0 (en) 2004-09-27

Family

ID=25528625

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16146802A IL161468A0 (en) 2001-10-19 2002-10-18 Method of producing human beta cell lines

Country Status (18)

Country Link
US (2) US20030077256A1 (fr)
EP (1) EP1456356B1 (fr)
JP (1) JP2005505635A (fr)
KR (1) KR20040080430A (fr)
CN (1) CN1662644A (fr)
AT (1) ATE452967T1 (fr)
BR (1) BR0213429A (fr)
CA (1) CA2463979A1 (fr)
DE (1) DE60234862D1 (fr)
GB (1) GB2397825B (fr)
HR (1) HRP20040446A2 (fr)
HU (1) HUP0600102A2 (fr)
IL (1) IL161468A0 (fr)
NZ (1) NZ532965A (fr)
PL (1) PL370167A1 (fr)
RU (1) RU2004115108A (fr)
WO (1) WO2003033685A2 (fr)
ZA (1) ZA200403646B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1924690A4 (fr) * 2005-09-15 2009-07-29 Burnham Inst Medical Research Méthodes servant à rechercher par criblage des composés modulant l'activité du promoteur d'insuline
JP5636192B2 (ja) * 2007-02-21 2014-12-03 エス・ア・エール・エル アンドセルSarl Endocells 糖尿病の診断のためのヒト膵臓β細胞株
US8859286B2 (en) * 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
CN105579577A (zh) 2013-06-11 2016-05-11 哈佛学院校长同事会 SC-β细胞以及用于产生其的组合物和方法
WO2016100930A1 (fr) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Procédés de production de lymphocytes b dérivés de cellules souches et leurs procédés d'utilisation
US10443042B2 (en) 2014-12-18 2019-10-15 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof
EP3234110B1 (fr) 2014-12-18 2024-02-28 President and Fellows of Harvard College PROCÉDÉS DE GÉNÉRATION DE CELLULES ß DÉRIVÉES DE CELLULES SOUCHES ET LEURS UTILISATIONS
IL312134A (en) 2017-11-15 2024-06-01 Vertex Pharma Preparations for the production of islet cells and methods of use
AU2019320072A1 (en) 2018-08-10 2021-02-25 Vertex Pharmaceuticals Incorporated Stem cell derived islet differentiation
CN110029130A (zh) * 2019-04-24 2019-07-19 皖南医学院第一附属医院(皖南医学院弋矶山医院) 基于CRISPR/Cas9系统在Beta-TC-6细胞株中剔除Sidt2基因方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723333A (en) * 1995-02-10 1998-03-03 Regents Of The University Of California Human pancreatic cell lines: developments and uses

Also Published As

Publication number Publication date
CA2463979A1 (fr) 2003-04-24
ATE452967T1 (de) 2010-01-15
US20030077256A1 (en) 2003-04-24
WO2003033685A3 (fr) 2004-05-27
ZA200403646B (en) 2005-01-26
EP1456356B1 (fr) 2009-12-23
GB2397825B (en) 2006-02-22
GB0411052D0 (en) 2004-06-23
JP2005505635A (ja) 2005-02-24
KR20040080430A (ko) 2004-09-18
GB2397825A (en) 2004-08-04
PL370167A1 (en) 2005-05-16
HUP0600102A2 (en) 2006-05-29
BR0213429A (pt) 2004-11-09
RU2004115108A (ru) 2005-02-10
NZ532965A (en) 2006-04-28
US20030219418A1 (en) 2003-11-27
HRP20040446A2 (en) 2005-04-30
CN1662644A (zh) 2005-08-31
DE60234862D1 (de) 2010-02-04
EP1456356A2 (fr) 2004-09-15
WO2003033685A2 (fr) 2003-04-24

Similar Documents

Publication Publication Date Title
AU2003208567A8 (en) Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
GB2397825B (en) Method of producing human beta cell lines
TR199903142T2 (xx) Pankreas dokusu adac��� transplantasyonu i�in CD154 blokaj tedavisi.
DE60039160D1 (de) Verwendung von erbb-rezeptorliganden zur behandlung von diabetes
DE60334534D1 (de) Chimäre bauchspeicheldrüse
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
AU2001245319A1 (en) Methods of treating diseases with activated protein c
IL137410A0 (en) A method for the production of transgenic plants using apical shoot tips
WO2004030628A3 (fr) Cellules souches derivees de la moelle osseuse adulte
BR0009636B1 (pt) processo para a preparação de insulina madura ou um derivado de insulina madura.
MXPA02002444A (es) Metodo para generar celulas y tejidos inmunocompatibles, utilizando tecnicas de transferencia nuclear.
GB9907048D0 (en) Novel glucocorticoid receptor ligands for the treatment of meta bolic disorders
FR2801900B1 (fr) Methode de production de cellules animales adherentes
DE59909197D1 (de) Verfahren zur auslösung von apoptose in zellen
WO2004078956A3 (fr) Procede nouveau pour detacher des cellules confluentes de microsupports bidimensionnels et son application pour preparer des transplantations
DE59914749D1 (de) Ustilipide, verfahren zu deren herstellung sowie deren verwendung
ATE525463T1 (de) Genomisches tabaknikotindemethylaseklon und verwendung
MX9709748A (es) Uso de lineas celulares fetales neuro-derivadas para terapia de trasplante.
HK1077306A1 (en) Ocular gene therapy
UA39614A (uk) Спосіб корекції функціонального стану міокарда у лабораторних тварин пізнього онтогенезу
ATE269090T1 (de) Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv
RU96122257A (ru) Способ лечения расстройств центральной нервной системы
UA32157A (uk) Спосіб лікування діабетичної ретинопатії